Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_assertion type Assertion NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_head.
- NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_assertion description "[Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_provenance.
- NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_assertion evidence source_evidence_literature NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_provenance.
- NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_assertion SIO_000772 20126311 NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_provenance.
- NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_assertion wasDerivedFrom befree-20140225 NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_provenance.
- NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_assertion wasGeneratedBy ECO_0000203 NP504502.RAW0B4fongRiJIFZ9tAPtjOokyzz-hCe5wVfwGxzV-mlE130_provenance.